Publicaties
- Chen WJ, Krul-Poel YH, Roth C, Labots M, van der Eertwegh AJ, Dreijerink KM. Endocriene bijwerkingen van immuuntherapie bij kanker; valkuilen bij de behandeling met checkpoint- remmers. Ned Tijdschr Geneeskd. 2019;163:D3957.
- Chen WJ, Diamant M, de Boer K, Harms HJ, Robbers LF, van Rossum AC, Kramer M, Lammertsma AA, Knaapen P. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine. Cardiovasc Diabetol. 2017 May 19;16(1):67.
- Favre J, Yildirim C, Leyen TA, Chen WJ, van Genugten RE, van Golen LW, Garcia-Vallejo JJ, Musters R, Baggen J, Fontijn R, van der Pouw Kraan T, Serné EH, Koolwijk P, Diamant M, Horrevoets AJ. Palmitic acid increases pre-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol. Vascul Pharmacol. 2015:S1537- 1891(15)00179-2.
- Van der Pouw Kraan TC, Chen WJ, Bunck MC, van Raalte DH, van der Zijl NJ, van Genugten RE, van Bloemendaal L, Baggen JM, Serné EH, Diamant M, Horrevoets AJ. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. BMC Med Genomics. 2015;8:20.
- Van der Pouw Kraan TC, Bernink FJ, Yildirim C, Koolwijk P, Baggen JM, Timmers L, Beek AM, Diamant M, Chen WJ, van Rossum AC, van Royen N, Horrevoets AJ, Appelman YE. Systemic toll- like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction. J Moll Cell Cardiol. 2014;67:94-102.
- Chen WJ, Danad I, Halbmeijer R, Raijmakers PG, Harms HJ, Lammertsma AA, van Rossum AC, Diamant M, Knaapen P. Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function. Am J Cardiol 2014;113:90-7.
- Chen WJ/Greulich S, van der Meer RW, Rijzewijk LJ, Lamb HJ, de Roos A, Smit JW, Romijn JA, Lammertsma AA, Lubberink M, Diamant M, Ouwens DM. Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in uncomplicated type diabetes. Cardiovasc Diabetol. 2013;12:150.
- Chen WJ/Greulich S, Maxhera B, Rijzewijk LJ, van der Meer RW, Jonker JT, Mueller H, Herzfeld de Wiza D, Flörke RR, Smiris K, Lamb HJ, de Roos A, Bax JJ, Romijn JA, Smit JW, Akhyari P, Lichtenberg A, Eckel J, Diamant M, Ouwens DM. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLos One. 2013;8:e59697.
- Bernink FJ, Timmers L, Diamant M, Scholte M, Beek AM, Kamp O, Marques KM, Denham RN, Chen WJ, Doevendans PA, van Rossum AC, van Royen N, Horrevoets AJ, Appelman Y. Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study. Int J Cardiol. 2013;167:289-90.
- de Haan S, Harms HJ, Lubberink M, Allaart CP, Danad I, Chen WJ, Diamant M, van Rossum AC, Iida H, Lammertsma AA, Knaapen P. Parametric imaging of myocardial viability using 15O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR. Eur J Nucl Med Mol Imaging. 2012;39:1240-4.
- Scholte M, Timmers L, Bernink FJ, Denham RN, Beek AM, Kamp O, Diamant M, Horrevoets AJ, Niessen HW, Chen WJ, van Rossum AC, van Royen N, Doevendans PA, Appelman Y. Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials. 2011;12:240.
Chen WJ, Rijzewijk LJ, van der Meer RW, Heymans MW, van Duinkerken E, Lubberink M, Lammertsma AA, Lamb HJ, de Roos A, Romijn JA, Smit JW, Bax JJ, Bjerre M, Frystyk J, Flyvbjerg A, Diamant M. Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovasc Diabetol 2011;10:67.
